Target Audience and Goal Statement
This activity is intended for cardiologists, ED physicians, critical care specialists, nurses, NPs, and all clinicians interested
in the prevention of SCD.
The goal of this activity is to update participants on the latest guidelines and data regarding the prevention of SCD and
application to clinical practice.
Upon completion of this activity, participants will:
- Have increased knowledge regarding the
- Emerging clinical data on the use of wearable cardioverter-defibrillators to prevent SCD
- Latest clinical guidelines on patient selection for SCD
- Have greater competence related to
- Use of effective multidisciplinary strategies to prevent SCD in patients at risk
Disclosures
As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of
an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant
financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial
relationships of a spouse or life partner, that could create a conflict of interest.
Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food
and Drug Administration, at first mention and where appropriate in the content.
Moderator

-
Sunil V. Rao, MD
Professor of Medicine, Duke University Medical Center; Section Chief, Cardiology, Durham VA Medical Center, Durham, North
Carolina
Disclosures
Disclosure: Sunil V. Rao, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Corindus, Inc.; Medtronic, Inc.; Philips Healthcare; Volcano Corporation
Dr Rao does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA
for use in the United States.
Dr Rao does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the
FDA for use in the United States.
Panelists

-
Anne B. Curtis, MD, MACP
SUNY Distinguished Professor; Charles and Mary Bauer Professor and Chair, Department of Medicine, University at Buffalo, Buffalo,
New York
Disclosures
Disclosure: Anne B. Curtis, MD, MACP, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbott Laboratories; Novartis Pharmaceuticals Corporation; Sanofi
Served as a speaker or a member of a speakers bureau for: Abbott Laboratories; Medtronic, Inc.
Dr Curtis does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the
FDA for use in the United States.
Dr Curtis does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by
the FDA for use in the United States.

-
Byron K. Lee, MD, MAS
Professor of Medicine; Samuel T. and Elizabeth Webb Reeves Endowed Chair in Arrhythmia Research; Director, Electrophysiology
Laboratories and Clinics, University of California, San Francisco
Disclosures
Disclosure: Byron K. Lee, MD, MAS, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Zoll Medical Corporation
Dr Lee does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA
for use in the United States.
Dr Lee does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the
FDA for use in the United States.

-
Jeffrey E. Olgin, MD
Gallo-Chatterjee Distinguished Professor of Medicine; Chief, Division of Cardiology; Co-Director, UCSF Heart and Vascular
Center, University of California San Francisco
Disclosures
Disclosure: Jeffrey E. Olgin, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Zoll Medical Corporation
Dr Olgin does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the
FDA for use in the United States.
Dr Olgin does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the
FDA for use in the United States.
Editor(s)
-
Beverly A. Caley, JD
Medical Writer, Caley-Reidenbach Consulting, LLP, Philomath, OR
Disclosures
Disclosure: Beverly A. Caley, JD, has disclosed no relevant financial relationships.
CME Revivewer / Nurse Planner
Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbot; Medtronic
Accreditation Statements
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical
Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC),
to provide continuing education for the healthcare team.
For Physicians
-
Medscape, LLC designates this enduring material for a maximum of 0.50
AMA PRA Category 1 Credit(s)™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Medscape, LLC staff have disclosed that they have no relevant financial relationships.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant
to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity
provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Aggregate participant data will be shared with commercial supporters of this activity.
Contact This Provider
For questions regarding the content of this activity, contact the
accredited provider for this CME/CE activity noted above. For technical
assistance, contact [email protected]
Instructions for Participation and Credit
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
- Read the target audience, learning objectives, and author disclosures.
- Study the educational content online or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated
at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.